Match!
Eduardo Verde
Hospital General Universitario Gregorio Marañón
Renal functionIntensive care medicineKidney diseaseDiabetes mellitusMedicine
68Publications
12H-index
611Citations
What is this?
Publications 68
Newest
#1Adriana Acosta Barrios (Hospital General Universitario Gregorio Marañón)
#2Marian Goicoechea (Hospital General Universitario Gregorio Marañón)H-Index: 23
Last. Jose Luis Luño Fernández (Hospital General Universitario Gregorio Marañón)H-Index: 1
view all 10 authors...
Source
#1Javier Carbayo (Hospital General Universitario Gregorio Marañón)H-Index: 2
Last. Marian GoicoecheaH-Index: 23
view all 10 authors...
Source
#1Marian Goicoechea (Hospital General Universitario Gregorio Marañón)H-Index: 23
Last. Eduardo Verde (Hospital General Universitario Gregorio Marañón)H-Index: 12
view all 26 authors...
SARS-CoV-2-pneumonia emerged in Wuhan, China in December 2019. Unfortunately, there is lack of evidence about the optimal management of novel coronavirus disease 2019 (COVID-19), even less in patients on maintenance hemodialysis (MHD) therapy than in the general population. In this retrospective observational single-center study we analyzed the clinical course and outcomes of all MHD patients hospitalized with COVID-19 from March 12th to April 10th, 2020 as confirmed by real time polymerase chai...
2 CitationsSource
#1Ana García-Prieto (Hospital General Universitario Gregorio Marañón)H-Index: 5
#2Ursula Verdalles (Hospital General Universitario Gregorio Marañón)H-Index: 11
Last. Marian Goicoechea (Hospital General Universitario Gregorio Marañón)H-Index: 23
view all 9 authors...
Abstract Introduction Blood pressure (BP) control is fundamental to the care of patients with chronic kidney disease (CKD), and is relevant at all stages of CKD. Renin–angiotensin–aldosterone system (RAAS) blockers have shown to be effective, not only in BP control but also in reducing proteinuria and slowing CKD progression. However, there is a lack of evidence for recommending RAAS blockers in elderly patients with CKD without proteinuria. The primary outcome of the present study is to evaluat...
Source
#1Ursula Verdalles (Hospital General Universitario Gregorio Marañón)H-Index: 11
#2Marian Goicoechea (Hospital General Universitario Gregorio Marañón)H-Index: 23
Last. José Luño (Hospital General Universitario Gregorio Marañón)H-Index: 23
view all 8 authors...
Abstract Introduction Actually, there are few data about glomerular filtration rate (eGFR) drop in patients with resistant hypertension and how different therapies can modify chronic kidney disease progression (CKD). Objective To evaluate CKD progression in patients with resistant hypertension undergoing two different therapies: treatment with spironolactone or furosemide. Methods We included 30 patients (21 M, 9 W) with a mean age of 66.3 ± 9.1 years, eGFR 55.8 ± 16.5 ml/min/1.73 m², SBP 162.8 ...
Source
#1Ursula Verdalles (Hospital General Universitario Gregorio Marañón)H-Index: 11
#2Marian Goicoechea (Hospital General Universitario Gregorio Marañón)H-Index: 23
Last. José Luño (Hospital General Universitario Gregorio Marañón)H-Index: 23
view all 8 authors...
Resumen Introduccion En la actualidad, existen pocos datos sobre la evolucion de la funcion renal en pacientes con hipertension arterial (HTA) resistente y enfermedad renal cronica (ERC), asi como de la influencia de diferentes tipos de tratamiento en dicha progresion. Objetivo Evaluar la progresion de la ERC en pacientes con ERC e HTA resistente tratados mediante 2 estrategias terapeuticas diferentes: tratamiento con espironolactona vs. furosemida. Metodos Incluimos a 30 pacientes (21 H, 9 M) c...
Source
#1Angel Sevillano (Complutense University of Madrid)H-Index: 9
#2Monserrat DiazH-Index: 1
Last. Manuel Praga (Complutense University of Madrid)H-Index: 48
view all 41 authors...
Background and objectives Some studies suggest that the incidence of IgA nephropathy is increasing in older adults, but there is a lack of information about the epidemiology and behavior of the disease in that age group. Design, setting, participants, & measurements In this retrospective multicentric study, we analyzed the incidence, forms of presentation, clinical and histologic characteristics, treatments received, and outcomes in a cohort of 151 patients ≥65 years old with biopsy-proven IgA n...
1 CitationsSource
#1Alejandra Muñoz de Morales (Hospital General Universitario Gregorio Marañón)H-Index: 1
#2Marian Goicoechea (Hospital General Universitario Gregorio Marañón)H-Index: 23
Last. José Luño (Hospital General Universitario Gregorio Marañón)H-Index: 23
view all 9 authors...
Background Pentoxifylline could reduce proteinuria and slow renal disease progression. We previously conducted a single-blind, randomized, controlled trial that showed that pentoxifylline decreases inflammatory markers and stabilizes renal function.
Source
#1Diego Barbieri (Hospital General Universitario Gregorio Marañón)H-Index: 2
#2Ana García-Prieto (Hospital General Universitario Gregorio Marañón)H-Index: 5
Last. José Luño (Hospital General Universitario Gregorio Marañón)H-Index: 23
view all 6 authors...
: Mixed cryoglobulinaemia (MCG) is one of the most severe extrahepatic hepatitis C virus (HCV)-associated complications, and could involve several organs, including the kidney. MCG prognosis relies on HCV response to antiviral treatment and has changed over the last years, especially after the introduction of new direct acting antivirals (DAA). MCG persistence despite sustained virological response (SVR) is uncommon and has a poorly known meaning and prognosis. We report a case of a patient with...
1 CitationsSource
#1Javier Carbayo (Hospital General Universitario Gregorio Marañón)H-Index: 1
#2Marian Goicoechea (Hospital General Universitario Gregorio Marañón)H-Index: 23
Last. José Luño (Hospital General Universitario Gregorio Marañón)H-Index: 23
view all 10 authors...
Source
1234567